BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Phan K, Sebaratnam DF. JAK inhibitors for alopecia areata: a systematic review and meta-analysis. J Eur Acad Dermatol Venereol. 2019;33:850-856. [PMID: 30762909 DOI: 10.1111/jdv.15489] [Cited by in Crossref: 39] [Cited by in F6Publishing: 23] [Article Influence: 19.5] [Reference Citation Analysis]
Number Citing Articles
1 Dillon KL. A Comprehensive Literature Review of JAK Inhibitors in Treatment of Alopecia Areata. Clin Cosmet Investig Dermatol 2021;14:691-714. [PMID: 34211288 DOI: 10.2147/CCID.S309215] [Reference Citation Analysis]
2 Arora CJ, Khattak FA, Yousafzai MT, Ibitoye BM, Shumack S. The effectiveness of Janus kinase inhibitors in treating atopic dermatitis: A systematic review and meta-analysis. Dermatol Ther 2020;33:e13685. [PMID: 32463149 DOI: 10.1111/dth.13685] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
3 Cogan NG, Bao F, Paus R, Dobreva A. Data assimilation of synthetic data as a novel strategy for predicting disease progression in alopecia areata. Math Med Biol 2021:dqab008. [PMID: 34109398 DOI: 10.1093/imammb/dqab008] [Reference Citation Analysis]
4 Montilla AM, Gómez-García F, Gómez-Arias PJ, Gay-Mimbrera J, Hernández-Parada J, Isla-Tejera B, Ruano J. Scoping Review on the Use of Drugs Targeting JAK/STAT Pathway in Atopic Dermatitis, Vitiligo, and Alopecia Areata. Dermatol Ther (Heidelb) 2019;9:655-83. [PMID: 31606872 DOI: 10.1007/s13555-019-00329-y] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 8.0] [Reference Citation Analysis]
5 Chapman S, Gold LS, Lim HW. Janus kinase inhibitors in dermatology: Part II. A comprehensive review. J Am Acad Dermatol 2021:S0190-9622(21)02022-3. [PMID: 34228996 DOI: 10.1016/j.jaad.2021.06.873] [Reference Citation Analysis]
6 Ramos PM, Anzai A, Duque-Estrada B, Melo DF, Sternberg F, Santos LDN, Alves LD, Mulinari-Brenner F. Consensus on the treatment of alopecia areata - Brazilian Society of Dermatology. An Bras Dermatol 2020;95 Suppl 1:39-52. [PMID: 33183894 DOI: 10.1016/j.abd.2020.05.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Solimani F, Meier K, Ghoreschi K. Emerging Topical and Systemic JAK Inhibitors in Dermatology. Front Immunol 2019;10:2847. [PMID: 31849996 DOI: 10.3389/fimmu.2019.02847] [Cited by in Crossref: 52] [Cited by in F6Publishing: 39] [Article Influence: 26.0] [Reference Citation Analysis]
8 Ahn H, Lee SY, Jung WJ, Lee KH. Alopecia treatment using minimally manipulated human umbilical cord-derived mesenchymal stem cells: Three case reports and review of literature. World J Clin Cases 2021;9:3741-51. [PMID: 34046478 DOI: 10.12998/wjcc.v9.i15.3741] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Macaluso FS, Rodríguez-lago I. JAK Inhibition as a Therapeutic Strategy for Inflammatory Bowel Disease. CDM 2020;21:247-55. [DOI: 10.2174/1389200221666200310111409] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
10 Oka A, Takagi A, Komiyama E, Yoshihara N, Mano S, Hosomichi K, Suzuki S, Haida Y, Motosugi N, Hatanaka T, Kimura M, Ueda MT, Nakagawa S, Miura H, Ohtsuka M, Tanaka M, Komiyama T, Otomo A, Hadano S, Mabuchi T, Beck S, Inoko H, Ikeda S. Alopecia areata susceptibility variant in MHC region impacts expressions of genes contributing to hair keratinization and is involved in hair loss. EBioMedicine 2020;57:102810. [PMID: 32580135 DOI: 10.1016/j.ebiom.2020.102810] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
11 Dincer Rota D, Emeksiz MAC, Erdogan FG, Yildirim D. Experience with oral tofacitinib in severe alopecia areata with different clinical responses. J Cosmet Dermatol 2021;20:3026-33. [PMID: 33533091 DOI: 10.1111/jocd.13966] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Phan K, Phan S, Shumack S, Gupta M. Repigmentation in vitiligo using janus kinase (JAK) inhibitors with phototherapy: systematic review and Meta-analysis. J Dermatolog Treat 2020;:1-5. [PMID: 32096671 DOI: 10.1080/09546634.2020.1735615] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
13 Yale K, Pourang A, Plikus MV, Mesinkovska NA. At the crossroads of 2 alopecias: Androgenetic alopecia pattern of hair regrowth in patients with alopecia areata treated with oral Janus kinase inhibitors. JAAD Case Rep 2020;6:444-6. [PMID: 32382642 DOI: 10.1016/j.jdcr.2020.02.026] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Mesinkovska N, King B, Mirmirani P, Ko J, Cassella J. Burden of Illness in Alopecia Areata: A Cross-Sectional Online Survey Study. Journal of Investigative Dermatology Symposium Proceedings 2020;20:S62-8. [DOI: 10.1016/j.jisp.2020.05.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
15 El Aziz Ragab MA, Hassan EM, El Niely DAEM, Mohamed MM. Serum level of interleukin-15 in active alopecia areata patients and its relation to age, sex, and disease severity. Postepy Dermatol Alergol 2020;37:904-8. [PMID: 33603607 DOI: 10.5114/ada.2020.102103] [Reference Citation Analysis]
16 Kerkemeyer KLS, John JM, Sinclair R, Bhoyrul B. Response of alopecia areata of the beard to oral tofacitinib. Journal of the American Academy of Dermatology 2020;82:1228-30. [DOI: 10.1016/j.jaad.2019.10.058] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 5.0] [Reference Citation Analysis]
17 Zhou C, Li X, Wang C, Zhang J. Alopecia Areata: an Update on Etiopathogenesis, Diagnosis, and Management. Clin Rev Allergy Immunol 2021. [PMID: 34403083 DOI: 10.1007/s12016-021-08883-0] [Reference Citation Analysis]
18 Phan K, Lee G, Fischer G. Methotrexate in the treatment of paediatric alopecia areata: Retrospective case series and updated meta‐analysis. Australas J Dermatol 2020;61:119-24. [DOI: 10.1111/ajd.13206] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
19 Oba MC, Askin O, Balci Ekmekci O, Serdaroglu S. Correlation between serum granulysin level and clinical activity in patients with alopecia areata before and after tofacitinib therapy. J Cosmet Dermatol 2021;20:971-5. [PMID: 32808476 DOI: 10.1111/jocd.13598] [Reference Citation Analysis]
20 Steele L, Lee HL, Maruthappu T, O'Toole EA. The status and outcomes of registered clinical trials for Janus kinase inhibitors in alopecia areata: are unpublished trials being overlooked? Clin Exp Dermatol 2021. [PMID: 33608909 DOI: 10.1111/ced.14615] [Reference Citation Analysis]
21 Hamilton CE, Craiglow BG. JAK Inhibitors for the Treatment of Pediatric Alopecia Areata. J Investig Dermatol Symp Proc. 2020;20:S31-S36. [PMID: 33099381 DOI: 10.1016/j.jisp.2020.04.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
22 Pourang A, Mesinkovska NA. New and Emerging Therapies for Alopecia Areata. Drugs 2020;80:635-46. [PMID: 32323220 DOI: 10.1007/s40265-020-01293-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]
23 Burroway B, Griggs J, Tosti A. Alopecia totalis and universalis long‐term outcomes: a review. J Eur Acad Dermatol Venereol 2020;34:709-15. [DOI: 10.1111/jdv.15994] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]